ATREON SA is a Swiss digital health company developing software solutions for remote monitoring of inflammatory arthritis (e.g. rheumatoid and psoriatic arthritis). Its product, DETECTRA, enables patients to capture hand images and symptoms via a mobile app, allowing clinicians to remotely monitor disease activity and prioritize patients at risk of flare-ups. By supporting earlier intervention and more efficient triage, ATREON helps improve outcomes while optimizing healthcare resources. The technology originates from CHUV and includes proprietary digital biomarker approaches currently under clinical evaluation.
06.03.2026
Future of Health Grant 2026 Spring cohort unveiled (startupticker.ch)
03.06.2025
Un jubilé synonyme de renaissance (startupticker.ch)
26.08.2024
ATREON décroche la première bourse InnoDIGITAL (startupticker.ch)
No milestones
No Jobs
DETECTRA - Remote Monitoring for Inflammatory Arthritis
No Awards
Website:
atreon.ch/
Headquarter:
Pully
Foundation Date:
January 2021
Technology:
Sectors: